Prashant Kudva

Prashant Kudva has a diverse work experience in business development and investment banking. Prashant currently serves as the Vice President of Business Development at Emendo Biotherapeutics since March 2023. Prior to that, they were the Head of Business Development at Generian from June 2021 to March 2023. Prashant has also worked in business development roles at Editas Medicine, AMAG Pharmaceuticals, and Kaufman Hall. Prashant gained experience in investment banking as the Vice President of Healthcare Investment Banking at Kaufman Hall and as an Executive Director, Vice President, and Associate at Stifel Financial Corp. Prashant started their career as an Associate Director at Standard Chartered Bank and worked as a Senior Analyst at Lazard and an Analyst at Merrill Lynch.

Prashant Kudva's education history begins with a Bachelor's degree in Economics and Political Science from the University of Chicago, which they completed from 2002 to 2005. Then, from 2017 to 2019, they pursued a Master's degree in Biotechnology Enterprise and Entrepreneurship with a Focus on Regulatory Science from The Johns Hopkins University. Prashant also attended Harvard University, where they took courses in Biotechnology, and The London School of Economics and Political Science (LSE), where they completed a non-degree course in Macroeconomics.

In addition to their formal education, Prashant Kudva has obtained certifications in finance, including a Series 63 certification from Finra Corp. and a Series 79 certification, also from Finra Corp. Specific dates for when these certifications were obtained are not provided.